Nouvelles

 

Le Département de génie biomédical de l’Université McGill vient de mettre sur pied un nouveau certificat qui donnera aux étudiants les outils nécessaires pour traduire les avancées de la recherche en génie biomédical en solutions cliniques et commerciales.
 
Le certificat comprend trois principaux cours :
1. Le brevetage de dispositifs médicaux
2. Les affaires réglementaires et systèmes de gestion de la qualité
3. La conception et réalisation d’essais cliniques.

Cliquer ici pour plus de détails sur le certificat ou encore visiter le site Web de l’Université McGill pour en savoir davantage.

Newsfeed

Stem Cells News -- ScienceDaily

Read about today's stem cell research including novel stem cell technology and advances in understanding cancer stem cells.
  • Looking for the origins of schizophrenia
    Schizophrenia may be related to neurodevelopment changes, including brain's inability to create the appropriate vascular system, according to new study. The results broaden the understanding about the causes of this severe and disabling disorder, which affects about 1 percent of the world's population.
  • Minimizing risks of transplants
    A bone marrow transplant is often the only therapy available to save leukaemia patients, but the risk of complications is high. Nearly half of all patients experience an unwanted reaction of their immune system, which often attacks their skin and liver and in up to 50 percent of cases the intestines. Researchers have succeeded in deciphering what causes this in some instances life-threatening inflammation of the intestines.